Have a personal or library account? Click to login
Treatment of acne vulgaris: a literature review / Lečenje običnih akni (acne vulgaris) – pregled literature Cover

Treatment of acne vulgaris: a literature review / Lečenje običnih akni (acne vulgaris) – pregled literature

Serbian Journal of Dermatology and Venereology
Volume 2 (2010): Issue 1 (March 2010)
By: Milica Subotić and  Verica Đuran  
Open Access
|Feb 2013

References

  1. 1. Lello J, Pearl A, Arroll B. Prevalence of acne vulgaris in Auckland senior high school students. N Z Med J 1995;08:287-9.
    Search in Google Scholar
  2. 2. Gollnick H,Cunliffe W, Berson D, et al. Management of acne: a report from Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003;49(1 Suppl):S1-37.10.1067/S0190-9622(03)02455-1
    Search in Google Scholar
  3. 3. Kubba R, Ajaj AK, Thappa DM, et al. Acne in India: guidelines for management-IAA consensus document. Genetics in acne. Indian J Dermatol Venereol Leprol 2009;75(Suppl 1):S4.
    Search in Google Scholar
  4. 4. Cunliffe WJ, Gollnick HPM. Acne: diagnosis and management. London: Martin Dunitz; 2001.p.1-46.
    Search in Google Scholar
  5. 5. Yazici K, Baz K, Yazici AE, Kokturk A, Tot S, Demirseren D, et al. Disease-specific quality of life associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venerol 2004;18:435-9.10.1111/j.1468-3083.2004.00946.x
    Search in Google Scholar
  6. 6. Dreno B. Assessing quality of life in patients with acne vulgaris. Am J Clin Dermatol 2006;7(2):99-106.10.2165/00128071-200607020-00003
    Search in Google Scholar
  7. 7. Ahmed S, Ahmed I. Frequency and magnitude of anxiety and depression among acne patients: a study of 100 cases. J Liaquat Uni Med Health Sci 2007;6(1):25-9.10.22442/jlumhs.07610110
    Search in Google Scholar
  8. 8. Burke BM, Cunliffe WJ. The assessment of acne vulgaris: leeds technique. Br J Dermatol 1984;111:83-92.10.1111/j.1365-2133.1984.tb04020.x
    Search in Google Scholar
  9. 9. Baldwin H. Tricks for improving compliance with acne therapy. Dermatol Ther 2006;19:224-36.10.1111/j.1529-8019.2006.00078.x
    Search in Google Scholar
  10. 10. Thielitz A, Gollnick H. Topical retinoids in acne vulgaris. Am J Clin Dermatol 2008;9(6):369-81.10.2165/0128071-200809060-00003
    Search in Google Scholar
  11. 11. Webster GF. Topical tretinoin in acne therapy. J Am Acad Dermatol 1998;39: S38-44.10.1016/S0190-9622(98)70443-8
    Search in Google Scholar
  12. 12. Lucky AW, Cullen SI, Jarratt MT, et al. Comparative efficacy and safety of two 0.0025% tretinoin gels: results from multicenter double-blind, parallel study. J Am Acad Dermatol 1998;38(4):S17-23.
    Search in Google Scholar
  13. 13. Irby CE, Yentzer BA, Feldman SR. A review of adapalene in the treatment of acne vulgaris. J Adolesc Health 2008;43:421-4.10.1016/j.jadohealth.2008.06.005
    Search in Google Scholar
  14. 14. Laboratories, Differin (adapalene) 0.3% gel product insert information, United States (online). Available from: URL:http:// www.differin.com/AboutDifferin/ProductInsert_Gel 0,3. aspx [Accessed 2010 Jan 28].
    Search in Google Scholar
  15. 15. Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet 1993;341:1181-2.10.1016/0140-6736(93)91004-6
    Search in Google Scholar
  16. 16. Chandraratna RA. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis. J Am Acad Dermatol 1997;37(Suppl 2 Pt 1):S12-7.10.1016/S0190-9622(97)80395-7
    Search in Google Scholar
  17. 17. Bershad S, Kranjac, Singer G, Parente J, Tan MH, Sherer D, Persuad AN, et al. Successful treatment of acne vulgaris using a new method. Arch Dermatol 2002;38:481-9.10.1001/archderm.138.4.481
    Search in Google Scholar
  18. 18. Krautheim A, Gollnick H. Acne: topical treatment. Clin Dermatol 2004;22:398-407.10.1016/j.clindermatol.2004.03.009
    Search in Google Scholar
  19. 19. Simonart T, Dramaix M. Treatment of acne with topical antibiotics: lessons from clinical studies. Br J Dermatol 2005;153:395-403.10.1111/j.1365-2133.2005.06614.x
    Search in Google Scholar
  20. 20. Poljački M, Subotić M, Đuran V, Matic M, Ivkov M. Terapija vulgarnih akni lokalnom elektroforetskom primenom klindamicina. U: II Kongres pedijatara Jugoslavije: zbornik sažetaka; 1998 sept. 20-26; Novi Sad, Jugoslavija. Novi Sad: Udruženje pedijatara Jugoslavije; 1998. str. 303-5.
    Search in Google Scholar
  21. 21. Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, Cunliffe WJ. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients:10-year surveillance data and snapshot distribution study. Br J Dermatol 2002;146:840-8.10.1046/j.1365-2133.2002.04690.x
    Search in Google Scholar
  22. 22. Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003;148:467-78.10.1046/j.1365-2133.2003.05067.x
    Search in Google Scholar
  23. 23. Cooper AJ. Systemic review of Propionibacterium acnes resistance to systemic antibiotics. Med J Aust 1998;169:259-61.10.5694/j.1326-5377.1998.tb140250.x
    Search in Google Scholar
  24. 24. Lookingbill DP, Chalker DK, Lindholm JS. Treatment of acne with combination of clindamycin/bezoylperoxyd gel compared with clindamycin gel, benzoylpreoxyde gel and combined results of two double blind investigations. J Am Acad Dermatol 1997;37:590-5.10.1016/S0190-9622(97)70177-4
    Search in Google Scholar
  25. 25. Katsambas A, Graupe K, Stratigos J. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin. Acta Derm Venereol Suppl (Stockh) 1989;143:35-9.
    Search in Google Scholar
  26. 26. Zhu YI, Stiller MJ. Dapsone and sulphones in dermatology: overview and update. J Am Acad Dermatol 2001;45:420-34.10.1067/mjd.2001.11473311511841
    Search in Google Scholar
  27. 27. Draelos ZD, Carter E, Maloney MJ, Elewski B, Poulin Y, Lynde C, et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol 2007;439:e1-10.10.1016/j.jaad.2006.10.00517208334
    Search in Google Scholar
  28. 28. Piette W, Taylor S, Pariser D, Jarratt M, Pranav S, Wilson D. hematologic safety of dapsone gel 5%, for topical treatment of acne vulgaris. Arch Dermatol 2008;144:1564-70.10.1001/archdermatol.2008.51819075138
    Search in Google Scholar
  29. 29. Gruber D, Sator M, Joura E, Kokoschka EM, Heinze G, Huber J. Topical cyproterone acetate treatment in women with acne. Arch Dermatol 1998;134:459-63.10.1001/archderm.134.4.4599554298
    Search in Google Scholar
  30. 30. Papageorgiou P, Kartsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol 2000;142:973-8.10.1046/j.1365-2133.2000.03481.x10809858
    Search in Google Scholar
  31. 31. Charakida A, Seaton E, Charakida M, Mouser P, Avgerinos A, Chu A. Phototherapy in the treatment of acne vulgaris. Am J Clin Dermatol 2004;5(4):211-6.10.2165/00128071-200405040-0000115301568
    Search in Google Scholar
  32. 32. Morton CA, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002;146:552-67.10.1046/j.1365-2133.2002.04719.x11966684
    Search in Google Scholar
  33. 33. Friedman P, Ming J, Kimyai-Asadi A, Goldberg L. Treatment of inflammatory facial acne vulgaris with the 1450-nm diode laser: a pilot study. Dermatol Surg 2004;30:147-51.10.1097/00042728-200402000-00006
    Search in Google Scholar
  34. 34. Goodman GJ. Management of post-acne scarring. What are the options for treatment? Am J Clin Dermatol 2000;1:3-17.10.2165/00128071-200001010-0000111702303
    Search in Google Scholar
  35. 35. Dreno B. Acne: physical treatment. Clin Dermatol 2004;22:429-33.10.1016/j.clindermatol.2004.03.01715556730
    Search in Google Scholar
  36. 36. Tan HH. Antibacterial therapy for acne. Am J Clin Dermatol 2003;4(5):307-14.10.2165/00128071-200304050-0000212688836
    Search in Google Scholar
  37. 37. Garner SE, Eady EA, Popescu C, et al. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev 2000;(2):CD002086.10.1007/BF03082691
    Search in Google Scholar
  38. 38. Sturkenboom MC, Meier CR, Jick H, et al. Minocyclin and lupus-like syndrome in acne patients. Arch Intern Med 1999;28:392-7.
    Search in Google Scholar
  39. 39. Bardazzi F, et al. Azitromycin: a new therapeutical strategy for acne in adolescents. Dermatol Online J 2008;13(4):4.
    Search in Google Scholar
  40. 40. Cooper AJ. Treatment of acne with isotretinoin: recommendations based on Australian experience. Aust J Dermatol 2003;44:97-105.10.1046/j.1440-0960.2003.00653.x
    Search in Google Scholar
  41. 41. Poljački M, Gajinov Z, Subotić M, Đuran V, Matić M. Izotretinoin u dermatoloskoj praksi. Med Pregl 1996;49(5-6):199-202.
    Search in Google Scholar
  42. 42. Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. Int J Neurobiol 2006;66:606-30.10.1002/neu.20242
    Search in Google Scholar
  43. 43. Reactive Holding Statement for postmarketing reports of severe skin reactions with use of isotretinoin. Basel: Roche; 2009.
    Search in Google Scholar
  44. 44. Chee Hong Ng, Schweitzer I. The association between depression and isotretinoin use in acne. Ausst N Z J Psychiatry 2003;37(1):78-84.10.1046/j.1440-1614.2003.01111.x
    Search in Google Scholar
  45. 45. Rubinow DR, Peck GL, Squillace KM, et al. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987;17:25-32.10.1016/S0190-9622(87)70166-2
    Search in Google Scholar
  46. 46. White GM, Chen W, Yao J, et al. Recurrence rate after first course of isotretinoin. Arch Dermatol 1998;134:376-8.10.1001/archderm.134.3.3769521042
    Search in Google Scholar
  47. 47. Huber J, Walch K. Treating acne with oral contraceptives: use of lower doses. Contraception 2006;73:23-9.10.1016/j.contraception.2005.07.01016371290
    Search in Google Scholar
  48. 48. Muhlemann MF, Carter GD, Cream JJ, Wise P. Oral spironolactone: an effective treatment for acne vulgaris in women. Br J Dermatol 1988;115:227-32.10.1111/j.1365-2133.1986.tb05722.x2943311
    Search in Google Scholar
  49. 49. Thilboutot D. Acne: hormonal concepts and therapy. Clin Dermatol 2004;22:419-28.10.1016/j.clindermatol.2004.03.01015556729
    Search in Google Scholar
  50. 50. Zouboulis C, Nestoris S, Adler YD, et al. A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipooxygenase inhibitor. Arch Dermatol 2003;139:668-70. 7.10.1001/archderm.139.5.66812756111
    Search in Google Scholar
  51. 51. Zouboulis CC, Seltmann H, Alestas T. Zileuton prevents the activation of the leukotriene pathway and reduces sebaceous lipogenesis. Exp Dermatol 2010;19:148-50.10.1111/j.1600-0625.2009.00929.x19645854
    Search in Google Scholar
  52. 52. Zouboulis CCh, Saborowski A, Boschnakow A. Zileuton, an Oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology 2005;210:36-8.10.1159/00008148115604543
    Search in Google Scholar
  53. 53. Farrar M, Howson K, Bojar R, et al. Genome sequence and analysis of a Propionibacterium acnes bacteriophage. J Bacteriol 2007;189(11):4161-7.10.1128/JB.00106-07191340617400737
    Search in Google Scholar
  54. 54. Nakatsuji T, Liu YT, Huang CP, Gallo R, Huang CM. antibodies elicited by inactivated Propionibacterium acnesbased vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: prevalence to therapy for acne vulgaris. J Invest Dermatol 2008;128:2451-7.10.1038/jid.2008.117307041918463682
    Search in Google Scholar
  55. 55. Kim J. Acne vaccines: therapeutic option for the treatment of acne vulgaris? J Invest Dermatol 2008;128:2451-7.
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10249-011-0018-8 | Journal eISSN: 2406-0631
Journal RSS Feed
Language: English
Page range: 13 - 20
Published on: Feb 12, 2013
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
Medicine,
Clinical medicine,
Dermatological and veneral diseases

© 2013 Milica Subotić, Verica Đuran, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons License.

Previous articleVolume 2 (2010): Issue 1 (March 2010)Next article